Literature DB >> 16959176

Evaluation and management of refractory overactive bladder.

Humphrey O Atiemo1, Sandip P Vasavada.   

Abstract

The refractory overactive bladder patient is a complex new entity for the urologic community. We present the most current review of this difficult subject matter with an emphasis on evaluation and new treatment options such as sacral neuromodulation and botulinum toxin injection. It is hoped that in this new era of medical innovation, extirpation and reconstruction of the bladder will become historic in nature and refractory therapy can be transitioned to the office and outpatient operation rooms.

Entities:  

Mesh:

Year:  2006        PMID: 16959176     DOI: 10.1007/s11934-006-0006-0

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   2.862


  40 in total

Review 1.  The natural history of the overactive bladder and detrusor overactivity. A review of the evidence regarding the long-term outcome of the overactive bladder.

Authors:  Stephen Garnett; Paul Abrams
Journal:  J Urol       Date:  2003-03       Impact factor: 7.450

2.  Effects of botulinum toxin B on refractory detrusor overactivity: a randomized, double-blind, placebo controlled, crossover trial.

Authors:  M Ghei; B H Maraj; R Miller; S Nathan; C O'Sullivan; C J Fowler; P J R Shah; J Malone-Lee
Journal:  J Urol       Date:  2005-11       Impact factor: 7.450

Review 3.  Diagnosis and treatment of overactive bladder.

Authors:  J J R Miller; P K Sand
Journal:  Minerva Ginecol       Date:  2005-10

Review 4.  Role of muscarinic receptor antagonists in urgency and nocturia.

Authors:  Martin C Michel; Jean J M C H de la Rosette
Journal:  BJU Int       Date:  2005-09       Impact factor: 5.588

5.  Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results.

Authors:  B Schurch; M Stöhrer; G Kramer; D M Schmid; G Gaul; D Hauri
Journal:  J Urol       Date:  2000-09       Impact factor: 7.450

6.  The role of neuromodulation in the management of urinary urge incontinence.

Authors:  P Abrams; J G Blaivas; C J Fowler; J L Fourcroy; S A Macdiarmid; S W Siegel; P Van Kerrebroeck
Journal:  BJU Int       Date:  2003-03       Impact factor: 5.588

Review 7.  Behavioral treatment options for urinary incontinence.

Authors:  Kathryn L Burgio
Journal:  Gastroenterology       Date:  2004-01       Impact factor: 22.682

8.  Upper urinary tract deterioration in patients with myelodysplasia and detrusor hypertonia: a followup study.

Authors:  E J McGuire; J R Woodside; T A Borden
Journal:  J Urol       Date:  1983-04       Impact factor: 7.450

9.  Use of botulinum-A toxin for the treatment of refractory overactive bladder symptoms: an initial experience.

Authors:  David E Rapp; Alvaro Lucioni; Erin E Katz; R Corey O'Connor; Glenn S Gerber; Gregory T Bales
Journal:  Urology       Date:  2004-06       Impact factor: 2.649

Review 10.  Current and future pharmacological treatment for overactive bladder.

Authors:  Naoki Yoshimura; Michael B Chancellor
Journal:  J Urol       Date:  2002-11       Impact factor: 7.450

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.